Table 8.

Symptom change of the total completer sample and patients with and without migratory background.

	Total sample T0-T1					Patients without MB T0-T1					Patients with MB T0-T1
	T	p	d	Resp*	Rem**	T	p	d	Resp*	Rem**	T	p	d	Resp*	Rem**
PHQ-15	5.818	<0.001	-0.287	23.8%	12.6%	5.888	<0.001	-0.337	24.4%	13.1%	1.404	0.167	-0.148	21.3%	10.6%
PHQ-15 *	5.936	<0.001	-0.299	–	–	5.888	<0.001	-0.345	–	–	1.575	0.122	-0.165	–	–
PHQ-9	12.447	<0.001	-0.759	54.8%	36.0%	11.324	<0.001	-0.771	53.9%	37.2%	5.161	<0.001	-0.727	58.3%	31.3%
GAD-7	9.187	<0.001	-0.638	44.3%	35.1%	8.621	<0.001	-0.687	46.2%	37.2%	3.267	0.002	-0.464	36.8%	26.3%
PCL-5	3.834	<0.001	-0.205	–	–	3.814	<0.001	-0.220	–	–	1.228	0.226	-0.165	–	–

MB, Migratory background; PHQ-15, Patient Health Questionnaire Somatization Module; * without Menstruation Item; PHQ-9, Patient Health Questionnaire Depression Module; GAD-7, General Anxiety Disorder Short Scale; PCL-5, PTSD-Checklist for DSM-5; Resp*, Response: RCI <-1.96; Rem**: Remission RCI <-1.96 and post value <10; varying sample sizes; significant p-values and the corresponding effect sizes are marked in bold.